Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
Apella Technology is an AI startup that brings modern engineering to improve surgery.
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Amplo Biotechnology is to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction.
Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company.
Vector Biomed is a state-of-the-art custom vector design and GMP manufacturing company.
Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.
ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers.
Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.
Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.
Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.
Exo Therapeutics is a small molecule drug discovery and development company.
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Loop Medical develops an easy and painless blood collection technology making it accessible to all.
Hexagon Bio is a data-driven biotech company developing targeted small molecule therapeutics.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Octave is a precision care company that provides diagnostic tools and care solutions for neurodegenerative diseases.
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3Kα malignancies.
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.
Casdin Capital has invested in 95 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Casdin Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 22 different industry categories.
Among tracked funding rounds, BBOT received $261.0M in a Post Ipo Equity round. Casdin Capital's total known invested capital is $8.1B.
Casdin Capital's average investment size is $93.1M across its portfolio of 95 companies.
Recent Casdin Capital portfolio additions include Foghorn Therapeutics, Apella Technology, Voyager Therapeutics, Amplo Biotechnology, Exai Bio. These companies were founded in 2020 or later.